Document:

Amendment, dated September 26, 2008

 Exhibit 10.2 
 AMENDMENT 
 This AMENDMENT (the “Amendment”) is entered into as of
September 26, 2008, by and between ISTA Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Highbridge International LLC (“Highbridge”). 
 RECITALS 
 WHEREAS, the Company issued $40,000,000 in aggregate principal amount
of Senior Subordinated Convertible Notes (the “Notes”) pursuant to that certain Securities Purchase Agreement (the “Agreement”), dated June 22, 2006, by and among the Company and the investors party thereto;

 WHEREAS, Highbridge purchased $2,000,000 in aggregate principal amount of Notes from the Company pursuant to the Agreement, and
subsequently purchased an additional $20,000,000 and $2,457,000 in aggregate principal amount of Notes on April 11, 2008 and September 25, 2008, respectively, and, as of the date hereof, is the beneficial owner of $24,457,000 in aggregate
principal amount of Notes; 
 WHEREAS, the Company and certain institutional accredited investors propose to enter a Facility Agreement
pursuant to which such investors shall lend the Company an aggregate principal amount of up to $65,000,000, upon the terms and conditions set forth in the Facility Agreement (the “Financing”); 
 WHEREAS, Highbridge and the Company desire to, among other things, amend the Notes to provide that the Company shall have the right to redeem the Notes,
at its election, at any time after their issuance at the price set forth in the Notes; 
 WHEREAS, Section 18 of the Notes provides, in
pertinent part, that the written consent of the holders of Notes representing at least a majority of the aggregate principal amount of the Notes outstanding shall be required for any change or amendment to the Notes; and 
 WHEREAS, Highbridge is the holder of Notes representing at least a majority of the aggregate principal amount of the Notes outstanding. 
 AGREEMENT 
 NOW, THEREFORE, in
consideration of the mutual agreements and covenants hereinafter set forth and for other valuable consideration, the Company and Highbridge hereby agree as follows: 
 1. Section 8(a) of each Note is hereby amended and restated in its entirety to read as follows: 
 “(a) Optional Redemption. The Company shall have the right to redeem all or any portion of the Conversion Amount then remaining under this Note as designated in the Optional Redemption Notice (an ‘Optional
Redemption’). The portion of this Note subject to redemption pursuant to this Section 8 shall be redeemed by the Company in cash at a price equal to 100% of the Conversion Amount being redeemed (the ‘Optional Redemption
Price’) on the Optional Redemption Date (as defined below). The Company may exercise its right to require redemption under this Section 8(a) by delivering a written notice thereof by facsimile and overnight courier to all, but not less
than all, of the holders of Notes and the Transfer Agent (the ‘Optional Redemption Notice’ and the date all of the holders received such notice is referred to as the ‘Optional Redemption Notice 

  

 1 

 
Date’), which Optional Redemption Notice shall be delivered promptly following such time as the Company closes on a debt financing transaction
with certain institutional accredited investors, whereby such investors shall lend the Company an aggregate principal amount of at least $40,000,000 and up to $65,000,000, upon the terms and conditions set forth in a Facility Agreement to be entered
into between the Company and such investors. The Optional Redemption Notice delivered shall be irrevocable and shall state (A) the date on which the Optional Redemption shall occur (the ‘Optional Redemption Date’) which date
shall be no later than five (5) Trading Days after the Optional Redemption Notice Date and (B) the aggregate Conversion Amount of the Notes which the Company has elected to be subject to Optional Redemption from all of the holders of the
Notes pursuant to this Section 8 (and analogous provisions under the Other Notes) on the Optional Redemption Date. All Conversion Amounts converted by the Holder after the Optional Redemption Notice Date shall reduce the Conversion Amount of
this Note required to be redeemed on the Optional Redemption Date. Redemptions made pursuant to this Section 8 shall be made in accordance with Section 13.” 
 2. Section 8(b) of each Note is hereby amended to add a sentence at the end of the paragraph, which shall read in its entirety as follows:

 “Notwithstanding anything else to the contrary contained herein, so long as the Company has delivered an Optional Redemption Notice to
each holder of Notes, then the Company need not effect the redemption of each such holder’s Notes on the same Optional Redemption Date.” 
 3. Section 31(o) of each Note is hereby amended to add a new subsection (vii), which shall read in its entirety as follows: 
 “and (vii) in connection with the issuance of warrants to purchase Common Stock of the Company, and in connection with any Common Stock actually issued upon the exercise of such warrants, issued in connection with a debt financing
transaction with certain institutional accredited investors providing for the incurrence of an aggregate principal amount of up to $65,000,000 of Indebtedness by the Company.” 
 4. Section 31(y) of each Note is hereby amended to add a new subsection (iv), which shall read in its entirety as follows: 
 “and (iv) Indebtedness in an aggregate principal amount of up to $65,000,000, together with any interest, fees and other amounts payable thereon
or in connection therewith, incurred by the Company in connection with a debt financing transaction with certain institutional accredited investors.” 
 5. Promptly following the closing of the Financing, the Company shall deliver, by facsimile and overnight courier, a written notice of its election to redeem the Notes to all, but not less than all, of the holders of
Notes and the Company’s transfer agent. Such notice shall be irrevocable and shall contain all of the information required to be contained in such notice pursuant to Section 8(a) of the Notes, as amended by this Amendment. 
 6. This Amendment shall be effective immediately upon the closing of the Financing. If the Financing does not occur on or before September 30, 2008,
this Amendment shall be null and void and have no force or effect. 
 7. Except as expressly amended, modified and/or supplemented herein,
all terms, covenants and provisions of the Notes are and shall remain in full force and effect and all references therein to the Notes, as applicable, shall henceforth refer to such instruments as amended by this Amendment. 
  

 2 

 8. This Amendment may be executed in any number of counterparts and by different parties hereto in
separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Amendment by
telecopy or electronic format (including pdf) shall be effective as delivery of a manually executed counterpart of this Amendment. 
 [REMAINDER OF PAGE INTENTIONALLY BLANK.] 
  

 3 

 IN WITNESS WHEREOF, this Amendment has been executed as of the date first above written. 
  

					
	ISTA PHARMACEUTICALS, INC.
		
	By:	 	/s/ Vicente Anido, Jr., Ph.D.
		 	Name: 	 	Vicente Anido, Jr., Ph.D.
		 	Title:	 	President and Chief Executive Officer
	
	HIGHBRIDGE INTERNATIONAL LLC
	By: Highbridge Capital Management, LLC,
	Its: Trading Manager
		
	By:	 	/s/ Adam J. Chill
		 	Name:	 	Adam J. Chill
		 	Title:	 	Managing DirectorRegistration Rights Agreement, dated September 26, 2008

 Exhibit 10.3 
 REGISTRATION RIGHTS AGREEMENT 
 REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of
September 26, 2008, by and between ISTA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (individually a “Lender”
and together, the “Lenders”). 
 WHEREAS: 
 A. In connection with the Facility Agreement by and between the parties hereto of even date herewith (the “Facility Agreement”), the Company has agreed, upon the terms and subject to the conditions contained
therein, to issue and sell to the Lenders Warrants (as defined below) in the amount described in the Facility Agreement, where each of the Warrants is exercisable into shares of the Company’s common stock, $0.001 value per share (the
“Common Stock”), each upon the terms and conditions and subject to the limitations and conditions set forth in the Warrants, all subject to the terms and conditions of the Facility Agreement; and 
 B. To induce the Lenders to execute and deliver the Facility Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933,
as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws, 
 NOW, THEREFORE, In consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company
and the Buyers hereby agree as follows: 
 1. DEFINITIONS. 
 a. As used in this Agreement, the following terms shall have the following meanings: 
 (i) “Additional Filing Deadline” means, with
respect to any additional Registration Statements that may be required pursuant to Section 2(a)(ii), the 30th day following (a) the date or time on which the SEC shall indicate as being the first date or time that such Registrable
Securities may then be included in a Registration Statement if such Registration Statement is required because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously
filed Registration Statement, or (b) if such additional Registration Statement is required for a reason other than as described in (a) above, the date on which the Company first knows, or reasonably should have known, that such additional
Registration Statement is required. 
 (ii) “Additional Registration Deadline” means, with respect to any additional Registration Statement(s) that
may be required to be filed pursuant to Section 2(a)(ii), the 90th day following (a) the date or time on which the SEC shall indicate as being the first date or time that such Registrable Securities may then be included in a Registration
Statement if such Registration Statement is required because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration Statement, or (b) if such
additional Registration Statement is required for a reason other than as described in (a) above, the date on which the Company first knows, or reasonably should have known, that such additional Registration Statement(s) is required. 

(iii) “Buyer” means any Lender and any transferee or assignee who agrees to become bound by the provisions of this Agreement in accordance with
Section 10 hereof. 
 (ii) “Filing Deadline,” for each Registration Statement required to be filed hereunder other than Section 2(a)(ii),
shall mean a date that is thirty (30) calendar days following the date the applicable Warrant is issued and, in the case of Section 2(a)(ii) shall mean the Additional Filing Deadline. 
 (iii) “Person” means and includes any natural person, partnership, joint venture, corporation, trust, limited liability company, limited company, joint stock
company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 

 (iv) “Registration Deadline” shall mean, other than for purposes of the Registration Statements required under
Section 2(a)(ii), the earlier of (i) the date that is ninety (90) days after the date that the applicable Registration Statement is actually filed or (ii) the date that is ninety (90) days after the applicable Filing
Deadline and, with respect to any Registration Statements required to be filed under Section 2(a)(ii), the Additional Registration Deadline. 
 (v)
“Warrant(s)” means the warrants issued by the Company pursuant to the Facility Agreement. 
 (vi) “Register,” “Registered,” and
“Registration” refer to a registration effected by preparing and filing a Registration Statement or Statements in compliance with the Securities Act and pursuant to Rule 415 under the Securities Act or any successor rule providing for
offering securities on a continuous basis, and the declaration or ordering of effectiveness of such Registration Statement by the United States Securities and Exchange Commission (the “SEC”). 
 (vii) “Registrable Securities,” for a given Registration, means (a) any shares of Common Stock (the “Warrant Shares”) issued or issuable upon
exercise of or otherwise pursuant to the Warrants (without giving effect to any limitations on exercise set forth in the Warrants), (b) any shares of capital stock issued or issuable as a dividend on or in exchange for or otherwise with respect
to any of the foregoing, (c) any other shares of common stock issuable pursuant to the terms of the Facility Agreement, the Warrants or this Registration Rights Agreement, and (d) any securities issued or issuable upon any stock split,
dividend or other distribution, recapitalization or similar event with respect to the foregoing. 
 (viii) “Registration Statement(s)” means a
registration statement(s) of the Company under the Securities Act required to be filed hereunder. 
 2. REGISTRATION. 
 a. MANDATORY REGISTRATION. (i) Following the issuance of any Warrants pursuant to the Facility Agreement, the Company shall prepare, and, on or prior to the
applicable Filing Deadline (as defined above) file with the SEC a Registration Statement (the “Mandatory Registration Statement”) on Form S-3 (or, if Form S-3 is not then available, on such form of Registration Statement as is then
available to effect a registration of the Registrable Securities, subject to the consent of the Buyers, which consent will not be unreasonably withheld) covering the resale of the Registrable Securities issued on the applicable Issuance Date (as
defined below) which Registration Statement, to the extent allowable under the Securities Act and the rules and regulations promulgated thereunder (including Rule 416), shall state that such Registration Statement also covers such indeterminate
number of additional shares of Common Stock as may become issuable upon exercise of or otherwise pursuant to the Warrants to prevent dilution resulting from stock splits, stock dividends, stock issuances or similar transactions. The number of shares
of Common Stock initially included in such Registration Statement shall be no less than the aggregate number of Warrant Shares that are then issuable upon exercise of or otherwise pursuant to the Warrants issued on the Issuance Date (as defined
herein), without regard to any limitation on the Buyers’ ability to exercise the Warrants, respectively. The Company acknowledges that the number of shares initially included in each Registration Statement represents a good faith estimate of
the maximum number of shares issuable upon exercise of or otherwise pursuant to the Warrants issued on the applicable Issuance Date and shall be amended if not sufficient. Each Registration Statement (and each amendment or supplement thereto, and
each request for acceleration of effectiveness thereof) shall be provided to (and subject to the approval, which shall not be unreasonably withheld, of) the Buyers and their counsel prior to its filing or other submission. 
 (ii) If for any reason the SEC does not permit all of the Registrable Securities to be included in the Registration Statement filed pursuant to Section 2(a)(i)
above, or for any other reason any Registrable Securities are not then included in a Registration Statement filed under this Agreement, then the Company shall prepare, and, as soon as practicable but in no event later than the Additional Filing
Deadline, file with the SEC an additional Registration Statement covering the resale of all Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to
Rule 415. 
  

 2 

 b. PIGGY-BACK REGISTRATIONS. If at any time prior to the expiration of the Registration Period (as hereinafter
defined) the Company shall determine to file with the SEC a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its securities (other than debt securities or securities being
registered on Form S-4 or Form S-8 or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with stock option or other
employee benefit plans), then the Company shall send to each Buyer written notice of such determination and, if within fifteen (15) days after the effective date of such notice, a Buyer shall so request in writing, the Company shall include in
such Registration Statement all or any part of such Buyer’s Registrable Securities the Buyer requests to be registered, except that if, in connection with any underwritten public offering for the account of the Company, the managing
underwriter(s) thereof shall impose a limitation on the number of Registrable Securities which may be included in the Registration Statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is
necessary to facilitate public distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable Securities with respect to which the Buyer has requested inclusion hereunder as
the underwriter shall permit; 
 PROVIDED, HOWEVER, that the Company shall not exclude any Registrable Securities unless the Company has first
excluded all outstanding securities, the holders of which are not entitled by contract to inclusion of such securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities; and 
 PROVIDED, FURTHER, HOWEVER, that, after giving effect to the immediately preceding proviso, any exclusion of Registrable Securities shall be made pro rata with
holders of other securities having the contractual right to include such securities in the Registration Statement other than holders of securities entitled to inclusion of their securities in such Registration Statement by reason of demand
registration rights. No right to registration of Registrable Securities under this Section 2(b) shall be construed to limit any registration required under Section 2(a) hereof. If an offering in connection with which a Buyer is entitled to
registration under this Section 2(b) is an underwritten offering, then such Buyer shall, unless otherwise agreed by the Company, offer and sell such Registrable Securities in an underwritten offering using the same underwriter or underwriters
and, subject to the provisions of this Agreement and the underwriting agreement in such offering, on the same terms and conditions as other shares of Common Stock included in such underwritten offering (including, without limitation, execution of an
agreement with the managing underwriter or agent limiting the sale or distribution such Buyer may make of shares of Common Stock or any securities convertible or exchangeable or exercisable for such shares of the Company, except as part of such
registration). Notwithstanding anything to the contrary set forth herein, the registration rights of a Buyer pursuant to this Section 2(b) shall only be available in the event the Company fails to timely file, obtain effectiveness or maintain
effectiveness of any Registration Statement to be filed pursuant to Section 2(a) in accordance with the terms of this Agreement. 
 3. OBLIGATIONS OF
THE COMPANY. In connection with the registration of the Registrable Securities, the Company shall have the following obligations: 
 a. The Company shall
prepare promptly, and file with the SEC as soon as practicable after each date that any Warrants are issued under the Facility Agreement (each an “Issuance Date”) (but no later than the Filing Deadline), a Registration Statement with
respect to the number of Registrable Securities provided in Section 2(a), and thereafter use its reasonable best efforts to cause each such Registration Statement relating to Registrable Securities to become effective as soon as possible after
such filing, but in any event shall cause each such Registration Statement relating to Registrable Securities to become effective no later than the Registration Deadline, and, subject to Section 3(q) hereof, shall keep the Registration
Statement current and effective pursuant to Rule 415 at all times until such date as is the earlier of (i) the date on which all of the Registrable Securities for such Registration Statement have been sold and (ii) the date on which all of
the Registrable Securities for such Registration Statement (in the opinion of counsel to the Buyers) may be immediately sold to the public without registration or restriction (including without limitation as to volume by each holder thereof) under
the Securities Act (the “Registration Period”), which Registration Statement (including any amendments or supplements thereto and prospectuses contained therein), except for information provided by a Buyer or any transferee of a Buyer
pursuant to Section 4(a) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading. 
  

 3 

 b. Subject to Section 3(q) hereof, the Company shall prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each Registration Statement as may be necessary to keep each Registration Statement current and effective at all times during the
Registration Period, and, during such period, comply with any applicable provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company covered by each Registration Statement until such time as all of
such Registrable Securities have been disposed of in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in each Registration Statement. 
 c. The Company shall furnish or otherwise make available (on EDGAR or otherwise) to each Buyer and its legal counsel (i) promptly after the same is prepared and publicly distributed, filed with the SEC, or
received by the Company, one copy of each Registration Statement and any amendment thereto, each preliminary prospectus and prospectus and each amendment or supplement thereto, and, in the case of a Registration Statement referred to in
Section 2(a), each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any
portion of any thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such
other documents as a Buyer may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Buyer. The Company will immediately notify the Buyers by facsimile of the effectiveness of each Registration
Statement or any post-effective amendment. The Company will promptly respond to any and all comments received from the SEC, with a view towards causing each Registration Statement or any amendment thereto to be declared effective by the SEC as soon
as practicable and shall file an acceleration request as soon as practicable, but no later than three (3) business days, following the resolution or clearance of all SEC comments or, if applicable, following notification by the SEC that any
such Registration Statement or any amendment thereto will not be subject to review. 
 d. The Company shall use its reasonable best efforts to
(i) register and qualify, in any jurisdiction where registration and/or qualification is required, the Registrable Securities covered by the Registration Statements under such other securities or “blue sky” laws of such jurisdictions
in the United States as the Buyers shall reasonably request, (ii) prepare and file in those jurisdictions such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to
maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all
other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (A) qualify to
do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), (B) subject itself to general taxation in any such jurisdiction, or (C) file a general consent to service of process in any
such jurisdiction. 
 e. Subject to Section 3(q) hereof, as promptly as practicable after becoming aware of such event, the Company shall notify each
Buyer who holds Registrable Securities of the happening of any event, of which the Company has knowledge, as a result of which the prospectus included in any Registration Statement, as then in effect, includes an untrue statement of a material fact
or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and use its reasonable best efforts promptly to prepare a supplement or amendment to any Registration Statement to correct
such untrue statement or omission, and deliver such number of copies of such supplement or amendment to each Buyer as such Buyer may reasonably request. 
 f. The Company shall use its reasonable best efforts to prevent the issuance of any stop order or other suspension of effectiveness of any Registration Statement, and, if such an order is issued, to obtain the withdrawal of such order at
the earliest possible moment and to notify each Buyer who holds Registrable Securities being sold (or, in the event of an underwritten offering, the managing underwriters) of the issuance of such order and the resolution thereof. 
 g. The Company shall permit a single firm of counsel designated by the Buyers to review such Registration Statement and all amendments and supplements thereto (as well
as all requests for acceleration or effectiveness thereof), at Buyers’ own cost, a reasonable period of time prior to their filing with the SEC (not less than five (5) business days but not more than eight (8) business days) use
reasonable best efforts to reflect in such documents any comments as such counsel may reasonably propose and will not request acceleration of such Registration Statement without prior notice to such counsel. 
  

 4 

 h. The Company shall hold in confidence and not make any disclosure of information concerning a Buyer provided to the
Company unless (i) disclosure of such information is necessary to comply with federal or state securities laws or the rules of any securities exchange or trading market on which the Company’s securities are then listed or traded,
(ii) the disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena or other order from a court or
governmental body of competent jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in violation of this or any other agreement. The Company agrees that it shall, upon learning that
disclosure of such information concerning such Buyer is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Buyer prior to making such disclosure, and allow such Buyer, at its
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information. 
 i. The Company shall use its
reasonable best efforts to cause all the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities of the same class or series issued by the Company are then listed, if any, if the
listing of such Registrable Securities is then permitted under the rules of such exchange, and, if listed on a national exchange, to arrange for at least two market makers to register with the Financial Industry Regulatory Authority, Inc.
(“FINRA”) as such with respect to such Registrable Securities. 
 j. The Company shall provide a transfer agent and registrar, which may be a
single entity, for the Registrable Securities not later than the effective date of the initial Registration Statement. 
 k. The Company shall cooperate with
each Buyer who holds Registrable Securities being offered and the managing underwriter or underwriters as reasonably requested by them with respect to an applicable Registration Statement, if any, to facilitate the timely preparation and delivery of
certificates (not bearing any restrictive legends) representing Registrable Securities to be offered pursuant to such Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the managing
underwriter or underwriters, if any, or the Buyer may reasonably request and registered in such names as the managing underwriter or underwriters, if any, or the Buyer may request, and, within three (3) business days after a Registration
Statement which includes Registrable Securities is ordered effective by the SEC, the Company shall deliver, and shall cause legal counsel selected by the Company to deliver, to the transfer agent for the Registrable Securities (with copies to each
Buyer) an appropriate instruction and an opinion of such counsel in the form required by the transfer agent in order to issue the Registrable Securities free of restrictive legends. 
 l. At the request of a Buyer, the Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to a Registration Statement and any prospectus used in connection
with the Registration Statement as may be necessary in order to change the plan of distribution set forth in such Registration Statement. 
 m. The Company
shall not, and shall not agree to, allow the holders of any securities of the Company (other than holders of Registrable Securities) to include any of their securities in any Registration Statement under Section 2(a) hereof or any amendment or
supplement thereto under Section 3(b) hereof without the consent of the Buyers. In addition, the Company shall not offer any securities for its own account or the account of others in any Registration Statement under Section 2(a) hereof or
any amendment or supplement thereto under Section 3(b) hereof without the consent of the Buyers. 
 n. The Company shall take all other reasonable
actions necessary to expedite and facilitate disposition by the Buyers of Registrable Securities pursuant to a Registration Statement. 
 o. The Company
shall comply with all applicable laws related to a Registration Statement and offering and sale of securities and all applicable rules and regulations of governmental authorities in connection therewith (including without limitation the Securities
Act and the Exchange Act and the rules and regulations promulgated by the SEC). 
 p. If required by the Financial Industry Regulatory Authority, Inc.
Corporate Financing Department, the Company shall promptly effect a filing with FINRA pursuant to FINRA Rule 2710 with respect to the public offering contemplated by resales of securities under the Registration Statement (an “Issuer
Filing”), and pay the filing fee required by such Issuer Filing. The Company shall use commercially reasonable efforts to pursue the Issuer Filing until FINRA issues a letter confirming that it does not object to the terms of the offering
contemplated by the Registration Statement. 
  

 5 

 (q) Notwithstanding anything to the contrary herein, at any time after a Registration Statement has been declared
effective by the SEC, the Company may delay or suspend the effectiveness of any Registration Statement or the use of any prospectus forming a part of the Registration Statement due to the non-disclosure of material, non-public information concerning
the Company the disclosure of which at the time is not in its best interest, in the good faith opinion of the Company (a “Grace Period”); provided, that the Company shall promptly notify each Buyer in writing of the existence of a Grace
Period in conformity with the provisions of this Section 3(q) and the date on which the Grace Period will begin (such notice, a “Commencement Notice”); and, provided further, that no Grace Period shall exceed 45 days, and such Grace
Periods shall not exceed an aggregate total of 60 days during any 12-month period. For purposes of determining the length of a Grace Period above, the Grace Period shall begin on and include the date specified by the Company in the Commencement
Notice and shall end on and include the date each Buyer receives written notice of the termination of the Grace Period by the Company (which notice may be contained in the Commencement Notice). The provisions of Sections 3(a)(ii), 3(b) and 3(e)
hereof shall not be applicable during any Grace Period. Upon expiration of the Grace Period, the Company shall again be bound by Sections 3(a)(ii), 3(b) and 3(e) with respect to the information giving rise thereto unless such material, non-public
information is no longer applicable. 
 (r) Notwithstanding anything else to the contrary contained in this Agreement, the Company’s obligations under
this Agreement (other than the obligations set forth in Sections 6, 7, 8, 9 and 12) shall terminate upon the expiration of the Registration Period. 
 4.
OBLIGATIONS OF THE BUYER. In connection with the registration of the Registrable Securities, each Buyer shall have the following obligations: 
 a. It
shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities of a Buyer that such Buyer shall furnish to the Company such information regarding
itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents
in connection with such registration as the Company may reasonably request. At least five (5) business days prior to the first anticipated filing date of a Registration Statement, the Company shall notify each Buyer of the information the
Company requires from such Buyer. Any such information shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading. A Buyer must
provide such information to the Company at least three (3) business days prior to the first anticipated filing date of such Registration Statement if such Buyer elects to have any Registrable Securities included in the Registration Statement.

 b. Each Buyer, by such Buyer’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of a Registration Statement hereunder, unless such Buyer has notified the Company in writing of the Buyer’s election to exclude all of the Buyer’s Registrable Securities from such Registration
Statement. 
 c. In the event of an underwritten offering pursuant to Section 2(b) in which any Registrable Securities are to be included, each Buyer
agrees to enter into and perform the Buyer’s obligations under an underwriting agreement, in usual and customary form, including, without limitation, customary indemnification and contribution obligations, with the managing underwriter of such
offering and take such other actions as are reasonably required in order to expedite or facilitate the disposition of the Registrable Securities, unless the Buyer has notified the Company in writing of the Buyer’s election to exclude all of the
Buyer’s Registrable Securities from such Registration Statement. 
 d. Each Buyer agrees that, upon receipt of any notice from the Company of the
happening of any event of the kind described in Section 3(e), 3(f) or 3(q), the Buyer will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until the
Buyer’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 3(e) or 3(f) or notice from the Company of the termination of the Grace Period, and, if so directed by the Company, the Buyer shall deliver to
the Company (at the expense of the Company) or destroy (and deliver to the Company a certificate of destruction) all copies in the Buyer’s possession, of the prospectus covering such Registrable Securities current at the time of receipt of such
notice. 
  

 6 

 5. REGISTRATION FAILURE. In the event of a Registration Failure (as defined in the Warrants), the Buyers shall be
entitled to Failure Payments (as defined in the Warrants) and such other rights as set forth in the Warrants. 
 6. EXPENSES OF REGISTRATION. All
reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualification
fees, printers and accounting fees, and the fees and disbursements of counsel for the Company shall be borne by the Company. 
 7. INDEMNIFICATION. In
the event any Registrable Securities are included in a Registration Statement under this Agreement: 
 a. The Company will indemnify, hold harmless and
defend (i) each Buyer, (ii) the directors, officers, partners, managers, members, employees, agents and each Person who controls any Buyer within the meaning of the Securities Act or the Exchange Act, if any, (iii) any underwriter (as
defined in the Securities Act) for each Buyer in connection with an underwritten offering pursuant to Section 2(b) hereof, and (iv) the directors, officers, partners, employees and each Person who controls any such underwriter within the
meaning of the Securities Act or the Exchange Act, if any (each, an “Indemnified Person”), against any joint or several losses, claims, damages, liabilities or expenses (collectively, together with actions, proceedings or inquiries by any
regulatory or self-regulatory organization, whether commenced or threatened, in respect thereof, “Claims”) to which any of them may become subject insofar as such Claims arise out of or are based upon: (i) any untrue statement or
alleged untrue statement of a material fact in a Registration Statement or the omission or alleged omission to state therein a material fact required to be stated or necessary to make the statements therein not misleading; (ii) any untrue
statement or alleged untrue statement of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration Statement, or contained in the final prospectus (as amended or supplemented, if the Company
files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein
were made, not misleading; or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities (the matters in the foregoing clauses (i) through (iii) being, collectively, “Violations”). The Company shall reimburse the Indemnified Person, promptly as such expenses are
incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the
indemnification agreement contained in this Section 7(a) (A) shall not apply to a Claim arising out of or based upon a Violation to the extent that such Violation occurs in reliance upon and in conformity with information furnished in
writing to the Company by any Indemnified Person for use in connection with the preparation of such Registration Statement or any such amendment thereof or supplement thereto; (B) with respect to any preliminary prospectus, shall not inure to
the benefit of any such Person from whom the Person asserting any such Claim purchased the Registrable Securities that are the subject thereof (or to the benefit of any Person controlling such Person) if the untrue statement or omission of material
fact contained in the preliminary prospectus was corrected in the prospectus, as then amended or supplemented, if such prospectus was timely made available by the Company pursuant to Section 3(d), and the Indemnified Person was promptly advised
in writing not to use the incorrect prospectus prior to the use giving rise to a violation and such Indemnified Person, notwithstanding such advice, used it or failed to deliver the correct prospectus as required by the Securities Act and such
correct prospectus was timely made available pursuant to Section 3(d); (C) shall not be available to the extent such Claim is based on a failure of the Indemnified Person to deliver or to cause to be delivered the prospectus made available
by the Company, including a corrected prospectus, if such prospectus or corrected prospectus was timely made available by the Company pursuant to Section 3(d); and (D) shall not apply to amounts paid in settlement of any Claim if such
settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the
Indemnified Person and shall survive the transfer of the Registrable Securities by a Buyer pursuant to Section 10. 
  

 7 

 b. Promptly after receipt by an Indemnified Person under this Section 7 of notice of the commencement of any action
(including any governmental action), such Indemnified Person shall, if a Claim in respect thereof is to be made against the Company under this Section 7, deliver to the Company a written notice of the commencement thereof, and the Company shall
have the right to participate in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory to the Company and the Indemnified Person, as the case may be. 
 PROVIDED, HOWEVER, that an Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the Company, if,
in the reasonable opinion of counsel for the Buyer, the representation by such counsel of the Indemnified Person and the Company would be inappropriate due to actual or potential differing interests between such Indemnified Person and any other
party represented by such counsel in such proceeding. The Company shall pay for only one separate legal counsel for the Indemnified Persons, and such legal counsel shall be selected by the Buyers. The failure to deliver written notice to the Company
within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnified Person under this Section 7, except to the extent that the Company is actually prejudiced in its ability to defend
such action. The indemnification required by this Section 7 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and
payable. 
 c. Each Buyer will indemnify, hold harmless and defend (i) the Company, and (ii) the directors, officers, partners, managers, members,
employees, or agents of the Company, if any (each, a “Company Indemnified Person”), against any Claims to which any of them may become subject insofar as such Claims arise out of or are based upon any Violation which occurs due to the
inclusion by the Company in a Registration Statement of false or misleading information about a Buyer, where such information was furnished in writing to the Company by such Buyer for the purpose of inclusion in such Registration Statement. Each
Buyer shall reimburse the Company Indemnified Person, promptly as such expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such
Claim. Notwithstanding anything herein to the contrary, the indemnity agreement contained in this Section 7(c) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the
Buyers which consent shall not be unreasonably withheld or delayed; and provided, further, however, that a Buyer shall be liable under this Section 7(c) for only that amount of a Claim as does not exceed the net amount of proceeds received
by such Buyer as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Company Indemnified Person.

 d. Promptly after receipt by a Company Indemnified Person under this Section 7 of notice of the commencement of any action (including any
governmental action), such Company Indemnified Person shall, if a Claim in respect thereof is to be made against a Buyer under this Section 7, deliver to such Buyer a written notice of the commencement thereof, and such Buyer shall have the
right to participate in, and, to the extent such Buyer so desires, to assume control of the defense thereof with counsel mutually satisfactory to such Buyer and the Company Indemnified Person, as the case may be. 
 PROVIDED, HOWEVER, that a Company Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the
applicable Buyer, if, in the reasonable opinion of counsel for the Company, the representation by such counsel of the Company Indemnified Person and such Buyer would be inappropriate due to actual or potential differing interests between such
Company Indemnified Person and any other party represented by such counsel in such proceeding. A Buyer shall pay for only one separate legal counsel for the Company Indemnified Persons, and such legal counsel shall be selected by the Company,
subject to the reasonable approval of such Buyer. The failure to deliver written notice to a Buyer within a reasonable time of the commencement of any such action shall not relieve the Buyer of any liability to the Company Indemnified Person under
this Section 7, except to the extent that the Buyer is actually prejudiced in its ability to defend such action. The indemnification required by this Section 7 shall be made by periodic payments of the amount thereof during the course of
the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable. 
 8. CONTRIBUTION. To the extent any
indemnification by the Company or a Buyer is prohibited or limited by law, the Company and each Buyer agrees to make the maximum contribution with respect to any amounts for which it would otherwise be liable under Section 7 to the fullest
extent permitted by law, based upon a comparative fault standard, provided that (i) no Person that is guilty of fraudulent misrepresentation (within the meaning Section 11(f) of the Securities Act) in connection with such sale shall be
entitled to contribution from any Person who was not guilty of fraudulent misrepresentation; and (ii) contribution by a Buyer shall be limited in amount to the net amount of proceeds received by the Buyer from the sale of such Registrable
Securities pursuant to a Registration Statement. 
  

 8 

 9. REPORTS UNDER THE 1934 ACT. With a view to making available to the Buyers the benefits of Rule 144
promulgated under the Securities Act or any other similar rule or regulation of the SEC that may at any time permit the Buyers to sell securities of the Company to the public without registration the Company agrees to: 
 a. make and keep public information available, as those terms are understood and defined in Rule 144; 
 b. file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements and the filing
of such reports and other documents is required for the applicable provisions of Rule 144; and 
 c. so long as the Buyers own Registrable Securities,
promptly upon request, (i) furnish to the Buyers a written statement by the Company that it has complied with the reporting requirements of the Securities Act and the Exchange Act as required for applicable provisions of Rule 144,
(ii) furnish or otherwise make available (on EDGAR or otherwise) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) furnish or otherwise make
available such other information as may be reasonably requested to permit the Buyers to sell such securities pursuant to Rule 144 without registration. 
 10. ASSIGNMENT OF REGISTRATION RIGHTS. The rights under this Agreement shall be automatically assignable by each Buyer to any transferee of all or any portion of the Registrable Securities if: (i) the Buyer agrees in writing
with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the Company within a reasonable time after such assignment, (ii) the Company is, within a reasonable time after such transfer or assignment,
furnished with written notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned, and (iii) at or before the time the
Company receives the written notice contemplated by clause (ii) of this sentence, the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein. In the event that a Buyer transfers all or
any portion of its Registrable Securities pursuant to this Section, such Buyer shall promptly notify the Company and the Company shall thereafter have at least ten (10) business days to file any amendments or supplements necessary to keep a
Registration Statement current and effective pursuant to Rule 415, and the commencement date of any Event of Failure (as defined in the Warrants) or Event of Default (as defined in the Warrants) under the Warrants caused thereby will be
extended by ten (10) days. 
 11. AMENDMENT OF REGISTRATION RIGHTS. Provisions of this Agreement may be amended and the observance thereof may be
waived (either generally or in a particular instance and either retroactively or prospectively), only with written consent of the Company and the holders of a majority in interest of then-outstanding Registrable Securities. Any amendment or waiver
effected in accordance with this Section 11 shall be binding upon each of the Buyers and the Company. 
 12. MISCELLANEOUS. 
 a. A Person is deemed to be a holder of Registrable Securities whenever such Person owns of record or beneficially through a “street name” holder such
Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election
received from the registered owner of such Registrable Securities. 
 b. Any notices required or permitted to be given under the terms hereof shall be sent
by certified or registered mail (return receipt requested) or delivered personally or by courier (including a recognized overnight delivery service) or by facsimile and shall be effective five days after being placed in the mail, if mailed by
regular United States mail, or upon receipt, if delivered personally or by courier (including a recognized overnight delivery service) or by facsimile, in each case addressed to a party. The addresses for such communications shall be: 
 If to the Company: 
 ISTA Pharmaceuticals, Inc. 
 15295 Alton Parkway 
 Irvine, CA 92618 
 Fax: (949) 789-7740 
 Attn: Chief Executive Officer 
  

 9 

 With copy to: 
 Stradling
Yocca Carlson & Rauth 
 660 Newport Center Drive, Suite 1600 
 Newport Beach, California 92660 
 Attention: Michael A. Hedge, Esq. 
 Fax: (949) 725-4100 
 If to a Buyer: 
 c/o Deerfield Capital, L.P. 
 780 Third Avenue, 37th Floor 
 New York, New York 10017 
 Fax: (212) 599-1248 
 Attn: Alexander Karnal 
 With a copy to: 
 Katten Muchin Rosenman LLP 
 575 Madison Avenue 
 New York, New York 10022 
 Fax: (212) 940-8776 
 Attn: Mark I. Fisher, Esq. 
 Elliot Press, Esq. 
 Each party shall provide notice to the other party of
any change in address. 
 c. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such
right or remedy, shall not operate as a waiver thereof. 
 d. Governing Law. All questions concerning the construction, validity, enforcement and
interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal
proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. The parties hereby waive all
rights to a trial by jury. If either party shall commence an action or proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. 
  

 10 

 e. This Agreement, the Warrants and the Facility Agreement (including all schedules and exhibits thereto) constitute the
entire agreement among the parties hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein. This Agreement, the
Warrants and the Facility Agreement supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof. 
 f. Subject to the requirements of Section 10 hereof, this Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto. 
 g. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. 
 h. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement.
This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement. 
 i. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements,
certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby. 
 j. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyers by vitiating the intent and purpose of the
transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for breach of its obligations hereunder will be inadequate and agrees, in the event of a breach or threatened breach by the Company of any of the
provisions hereunder, that the Buyers shall be entitled, in addition to all other available remedies in law or in equity, to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement and to enforce specifically the
terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required. 
 k. The language used in
this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 
 l. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.

 m. In the event a Buyer shall sell or otherwise transfer any of such holder’s Registrable Securities, each transferee shall be allocated a pro rata
portion of the number of Registrable Securities included in a Registration Statement for such transferor. 
 n. There shall be no oral modifications or
amendments to this Agreement. This Agreement may be modified or amended only in writing. 
 [Remainder of page left intentionally blank]

 [Signature page follows] 
  

 11 

 IN WITNESS WHEREOF, the undersigned Buyers and the Company have caused this Registration Rights Agreement
to be duly executed as of the date first written above. 
  

													
	COMPANY:	 	BUYER:
	ISTA PHARMACEUTICALS, INC.	 	DEERFIELD PRIVATE DESIGN FUND, L.P.
					
	By:	 	/s/ Vicente Anido, Jr., Ph.D.	 		 	By:	 	/s/ James Flynn
		 	Name: 	 	Vicente Anido, Jr., Ph.D.	 		 		 	Name: 	 	James Flynn
		 	Title:	 	President and Chief Executive Officer	 		 		 	Title:	 	General Partner
		
	BUYER:	 	BUYER:
	DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.	 	DEERFIELD SPECIAL SITUATIONS FUND, L.P.
					
	By:	 	/s/ James Flynn	 		 	By:	 	/s/ James Flynn
		 	Name: 	 	James Flynn	 		 		 	Name: 	 	James Flynn
		 	Title:	 	General Partner	 		 		 	Title:	 	General Partner
		
	BUYER:	 	BUYER:
	DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITED	 	SANDERLING VENTURE PARTNERS VI CO-INVESTMENT FUND, L.P.
		 	By: Middleton, McNeil, Mills & Associates VI, LLC
					
	By:	 	/s/ James Flynn	 		 	By:	 	/s/ Robert G. McNeil
		 	Name: 	 	James Flynn	 		 		 	Name: 	 	Robert G. McNeil
		 	Title:	 	General Partner	 		 		 	Title:	 	Managing Director
		
	BUYER:	 	BUYER:
	SANDERLING VI LIMITED PARTNERSHIP	 	SANDERLING VI BETEILIGUNGS GMBH & CO. KG
	By: Middleton, McNeil, Mills & Associates VI, LLC	 	
					
	By:	 	/s/ Robert G. McNeil	 		 	By:	 	/s/ Robert G. McNeil
		 	Name: 	 	Robert G. McNeil	 		 		 	Name: 	 	Robert G. McNeil
		 	Title:	 	Managing Director	 		 		 	Title:	 	Managing Director
		
	BUYER:	 	BUYER:
	SANDERLING VENTURES MANAGEMENT VI	 	SPROUT CAPITAL IX, L.P.
		 	By: DLJ Capital Corporation
		 	Its: Managing General Partner
					
	By:	 	/s/ Robert G. McNeil	 		 	By:	 	/s/ Craig L. Slutzkin
		 	Name: 	 	Robert G. McNeil	 		 		 	Name: 	 	Craig L. Slutzkin
		 	Title:	 	Owner	 		 		 	Title:	 	Attorney in Fact
		
	BUYER:	 	BUYER:
	SPROUT ENTREPRENEURS’ FUND, L.P.	 	SPROUT IX PLAN INVESTORS, L.P.
	By: DLJ Capital Corporation	 	By: DLJ LBO Plans Management Corporation II
	Its: General Partner	 	Its: General Partner
					
	By:	 	/s/ Craig L. Slutzkin	 		 	By:	 	/s/ Craig L. Slutzkin
		 	Name: 	 	Craig L. Slutzkin	 		 		 	Name: 	 	Craig L. Slutzkin
		 	Title:	 	Attorney in Fact	 		 		 	Title:	 	Attorney in Fact

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]